세계의 피임약 시장 규모는 2022년에 195억 달러로 평가되며, 2023년 210억 8,000만 달러에서 2031년에는 393억 1,000만 달러로 성장하며, 예측 기간 중(2024-2031년) CAGR은 8.1%로 성장할 전망입니다.
피임약과 디바이스 시장은 성감염증의 이환율 상승과 피임법을 사용할 수 없는 여성 증가로 인해 성장할 것으로 예상되고 있습니다. 세계보건기구(WHO)가 강조한 바와 같이, 2019년에는 11억 명 이상의 가임기 여성이 가족계획이 필요하며, 2억 7,000만 명이 충족되지 않은 수요를 경험하고 있습니다. 표적화된 프로그램과 인식 개선을 통해 계획되지 않은 임신에 대처하기 위한 노력은 시장 확대의 원동력이 될 것으로 예상됩니다. 반면, 피임약의 부작용, 불임률 증가에 대한 우려, 선진국의 성교육 불일치 등의 문제는 성장을 저해하는 요인으로 작용할 수 있습니다. 이러한 역학은 피임약 시장에서 접근성과 사용자 만족도를 높이기 위한 혁신적인 솔루션의 필요성을 강조하고 있습니다.
Global Contraceptive Drugs Market size was valued at USD 19.5 billion in 2022 and is poised to grow from USD 21.08 billion in 2023 to USD 39.31 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).
The market for contraceptive drugs and devices is poised for growth due to the rising incidence of sexually transmitted diseases and an increasing number of women lacking access to these options. As highlighted by the World Health Organization, in 2019, more than 1.1 billion women of reproductive age were in need of family planning, with 270 million experiencing unfulfilled demand. Efforts to address unplanned pregnancies through targeted programs and heightened awareness are expected to drive market expansion. Conversely, challenges such as side effects associated with contraceptives, concerns over growing infertility rates, and inconsistencies in sex education in developed nations may impede growth. These dynamics underscore the need for innovative solutions to enhance accessibility and user satisfaction in the contraceptive market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contraceptive Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Contraceptive Drugs Market Segmental Analysis
Global Contraceptive Drugs Market is segmented by type, distribution and region. Based on type, the market is segmented into oral contraceptives, combined oral contraceptive pills, progestogen-only pills, topical contraceptives, contraceptive injectable and others. Based on distribution, the market is segmented into hospital & clinics, retail pharmacy, online pharmacy and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Contraceptive Drugs Market
The Global Contraceptive Drugs market is significantly driven by the need to prevent unwanted pregnancies, particularly among poor and low-income populations where the incidence of unintended pregnancy remains high. A key factor behind this issue is the reliance on traditional contraception methods, which are often less effective. This situation is further compounded by the prevalence of unsafe abortions and associated maternal mortality rates. For instance, in Latin America, adolescents under 16 face a fourfold increase in the risk of maternal death compared to women in their thirties. Consequently, the adoption of contraceptive drugs plays a vital role in reducing the rates of unplanned pregnancies, thereby improving maternal health outcomes.
Restraints in the Global Contraceptive Drugs Market
The global contraceptive drugs market is facing significant constraints due to the adverse effects associated with birth control pills. Prolonged use, defined as ten years or more, can lead to various side effects including headaches, nausea, and abnormal bleeding. Additionally, medications that contain estrogen and progesterone have been linked to an elevated risk of developing blood clots, which can result in serious complications such as heart attacks. These potential health risks contribute to consumer hesitancy and reduce market demand, ultimately impeding the growth of the contraceptive drugs sector worldwide. Addressing these concerns is crucial for market expansion.
Market Trends of the Global Contraceptive Drugs Market
The Global Contraceptive Drugs market is experiencing a significant shift towards innovative technological advancements, particularly in the realm of digital contraception. This trend encompasses a growing emphasis on period tracking applications that empower users to monitor their menstrual cycles and assess pregnancy risk. A notable example is Berlin-based Clu's all-digital contraceptive, Clu Birth Control, which leverages comprehensive period data and predictive algorithms to enhance contraceptive efficiency. The ability for users to adjust their sexual behaviors based on personalized risk analytics positions digital contraception as a game-changer in reproductive health, reflecting a broader consumer demand for tailored, tech-driven contraceptive solutions.